Richard Smith

Q: What Schools Are Affiliated With Richard Smith

Richard Smith is affiliated with the following schools: University of California, Berkeley, University College London, Stanford University, University of Tennessee Health Science Center, King's College London, University of Cambridge

Richard Smith 's AcademicInfluence.com Rankings

Richard Smith

Earth Sciences

#2758

World Rank

#3703

Historical Rank

Geography

#603

World Rank

#836

Historical Rank

earth-sciences Degrees

Download Badge

Earth Sciences

Richard Smith 's Degrees

PhD Geography University of California, Berkeley
Masters Geography University of California, Berkeley
Bachelors Geography University of California, Berkeley

Why Is Richard Smith Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Richard Michael Smith, FBA, FRHistS is a historical geographer and demographer. He was professor of historical geography and demography at the University of Cambridge from 2003 to 2011, where he is now an emeritus professor, and served as director of the Cambridge Group for the History of Population and Social Structure . He was also a fellow of Downing College, Cambridge, from 1994 to 2010.

(See a Problem?)

Richard Smith 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis (1997) (265)
Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo (2005) (227)
Hyperparathyroidism and the Calcium Paradox of Aldosteronism (2005) (205)
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. (2008) (190)
Structural characterization of a highly–ordered ‘molten globule’ at low pH (1994) (124)
Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome (2005) (113)
An atomic resolution model for assembly, architecture, and function of the Dr adhesins. (2004) (113)
Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. (2005) (103)
Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. (2006) (100)
Molecular Dissection of Interactions between Components of the Alternative Pathway of Complement and Decay Accelerating Factor (CD55)* (2005) (96)
Loss of bone minerals and strength in rats with aldosteronism. (2004) (92)
Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria (2018) (92)
The CD46 and Jagged1 interaction is critical for human T helper 1 immunity (2012) (89)
Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. (2003) (87)
Generation of a Recombinant, Membrane-targeted Form of the Complement Regulator CD59 (2003) (65)
Pseudosubstrate peptides inhibit Akt and induce cell growth inhibition. (2004) (61)
A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial (2017) (57)
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide (1997) (57)
Structural Basis for Recognition of the Pore-Forming Toxin Intermedilysin by Human Complement Receptor CD59 (2013) (54)
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. (2006) (53)
Dynamics of the multidomain fibrinolytic protein urokinase from two-dimensional NMR (1989) (48)
Biological activity, membrane‐targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli (2004) (47)
HES1 in immunity and cancer. (2016) (45)
Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations (1997) (44)
Vitamin D analogs 17,20S(OH)2pD and 17,20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. (2011) (43)
Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1. (2007) (41)
Comparison of four independently determined structures of human recombinant interleukin–4 (1994) (37)
Helminth parasites of the raccoon (Procyon lotor) from Tennessee and Kentucky (1985) (36)
Structure‐activity relationships within the N‐terminal short consensus repeats (SCR) of human CR1 (C3b / C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation (1999) (35)
Instant Blood-Mediated Inflammatory Reaction in Hepatocyte Transplantation: Current Status and Future Perspectives (2016) (31)
Targeting complement at the time of transplantation. (2013) (30)
C1 Esterase Inhibitor Reduces Lower Extremity Ischemia/Reperfusion Injury and Associated Lung Damage (2013) (30)
Expression of Glycosylphosphatidylinositol-Anchored CD59 on Target Cells Enhances Human NK Cell-Mediated Cytotoxicity1 (2006) (27)
High-resolution structures of bacterially expressed soluble human CD59. (2007) (26)
Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes. (2006) (24)
The CD 46-Jagged 1 interaction is critical for human TH 1 immunity (2012) (23)
The Role of Putative Fibrinogen Aα-, Bβ-, and γA-chain Integrin Binding Sites in Endothelial Cell-mediated Clot Retraction* (1997) (18)
Disentangling the roles of cholesterol and CD59 in intermedilysin pore formation (2016) (17)
APT070 (mirococept), a membrane‐localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model (2016) (17)
Adhesion of microvascular endothelial cells to metallic implant surfaces (2000) (15)
Bacterial expression and membrane targeting of the rat complement regulator Crry: A new model anticomplement therapeutic (2002) (15)
Ex vivo delivery of Mirococept: A dose‐finding study in pig kidney after showing a low dose is insufficient to reduce delayed graft function in human kidney (2020) (15)
Prostate cancer cells enhance interleukin‐15‐mediated expansion of NK cells (2019) (14)
A Recombinant, Chimeric Enzyme With a Novel Mechanism of Action Leading to Greater Potency and Selectivit Than Tissue‐Type Plasminogen Activator (1992) (13)
Membrane-localising complement inhibitors-clinical progress (2007) (12)
Efficient production of complement (C3d)3 fusion proteins using the baculovirus expression vector system. (2005) (9)
[232] Amine oxidase (beef plasma) (1971) (9)
Immunotherapy of prostate cancer: identification of new treatments and targets for therapy, and role of WAP domain-containing proteins. (2011) (9)
Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model (2020) (8)
Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury (2017) (8)
Cell surface engineering using a complement regulatory molecule modified with a synthetic myristoyl-electrostatic switch derivative (1998) (8)
Characterization of protein kinase A phosphorylation: multi-technique approach to phosphate mapping. (2004) (7)
Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2 (2016) (7)
Preclinical and clinical progression of a membrane-targeted complement regulator therapeutic (2001) (6)
Does spatial assimilation lead to reproduction of gentrification in the global city? (2015) (6)
Regression of Atherosclerosis in ApoE−/− Mice Via Modulation of Monocyte Recruitment and Phenotype, Induced by Weekly Dosing of a Novel “Cytotopic” Anti‐Thrombin Without Prolonged Anticoagulation (2020) (5)
Pauper Policies: Poor Law Practice in England, 1780–1850 (2018) (4)
Corrigendum to “Efficient elutriation of monocytes within a closed system (Elutra™) for clinical-scale generation of dendritic cells” [Journal of Immunological Methods 298 (2005) 61–72] (2005) (4)
Expression of IL-15 and IL-2 cytokines and receptors on prostate cancer cells - significance in prostate immunotherapeutics (2013) (4)
Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking (2016) (3)
Localised inhibition of coagulation limits acute complement mediated damage in high risk renal transplantation (2012) (3)
1789 SELECTION OF OPTIMAL CYTOKINE COMBINATIONS FOR IMMUNOTHERAPY OF PROSTATE CANCER (2011) (3)
MP46-18 CD8 T CELLS INHIBIT THE INTERLEUKIN-15 (IL-15) INDUCED CYTOTOXIC ACTIVITY OF NK AND NKT CELLS TOWARD TUMOUR CELLS IN THE PROSTATE CANCER MICROENVIRONMENT. (2015) (2)
Integrating cytotopic strategy in transplantation: (1) Design of locally-acting coagulation inhibitors for use with anti-complement therapeutics (2010) (2)
210 Reversible ligation of proteins to the active centres of serine proteases: Application to the design of thrombolytic agents (1988) (2)
How Many Immigrant-Friendly Communities Are in the United States? Classifying the Policy Stream (2021) (2)
Local Government Incorporation of Immigrants in Community Economic Development Strategies (2012) (2)
Towards an integrated cytotopic strategy for graft modification in transplantation—Complement and coagulation (2009) (1)
Abstract 2833: The protein ps20 increases tumourigenic potential in prostate cancer epithelial cells (2012) (1)
Complement Inhibitor APT070 Dramatically Reduces the Need for Resuscitation and Improves Survival in Controlled Isobaric Rat Hemorrhage Model (2004) (1)
Structural studies of human CD59 and its ligands (2007) (1)
Mutation of duffy antigen receptor for chemokines (DARC) as an indicator of prostate cancer severity in Afro-Caribbean men (2017) (1)
Complotype affects the extent of down-regulation by Factor I of the C 3 b feedback cycle in-vitro 1 Short title : In-vitro effects of complotype (2014) (1)
243 IL-15 potentiates CD8 and NK effector cell expansion and tumour cell killing in the prostate cancer microenvironment (2012) (1)
A novel in vivo model using immunotoxin in the absence of p-glycoprotein to achieve ultra selective depletion of target cells: Applications in trogocytosis and beyond. (2020) (1)
Integrating cytotopic strategy in transplantation: (2) Localised co-inhibition of complement and coagulation in high risk renal transplantation (2010) (1)
Abstract 673: Use of membrane-tethered anti-thrombin compounds in prostate cancer therapy (2011) (1)
Mortality, Marriage and Population Growth in England, 1550–1850 (2017) (1)
Prospects for Online Crowdsourcing of Social Science Research Tasks: A Case Study Using Amazon Mechanical Turk (2014) (1)
Author Correction: Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury (2018) (0)
ENDOTHELIAL TARGETED ANTICOAGULATION IN KIDNEY ALLOGRAFTS USING A PORCINE MACHINE PERFUSION THROMBOSIS MODEL (2011) (0)
Ecosocial Work in Community Practice (2022) (0)
Abstract A11: Targeting prostate cancer using novel cytotopically modified immunotherapies intratumorally in a syngeneic murine model (2020) (0)
MP84-07 A TALE OF TAILS – A NOVEL APPROACH TO IMMUNOTHERAPY OF PROSTATE CANCER (2017) (0)
Soluble derivatives of the type complement receptor (CR1) (1993) (0)
Crystallographic studies of decay-accelerating factor (CD55) (2002) (0)
The C3-like molecule CD109 controls Th1 versus Th17 induction in CD4+ T cells (2016) (0)
Mechanism of activation of natural killer and CD8 T cells by interleukin 15 in the prostate cancer microenvironment (2014) (0)
Detection of innate immunity post ischaemia reperfusion injury in heart transplantation using SPECT imaging (2014) (0)
In vitro characterisation of an imaging ligand for detection of C3d deposition in vivo (2010) (0)
From Structure to Function of a Complement Regulator: Decay-Accelerating Factor (CD55) (2005) (0)
Solution structure of the engineered protein Afae-dsc (2005) (0)
Abstract 2340: IL-15 increases NK functions in the PCa-lymphocyte microenvironment by a profound increase in shedding of MICA from PCa cells - a novel paradigm (2015) (0)
High resolution structure of human CD59 (2007) (0)
328 PS20 INHIBITS EXPANSION OF CD8-T CELLS AND NK CELLS IN THE PROSTATE CANCER MICROENVIRONMENT AND INHIBITS KILLING OF PROSTATE CANCER CELLS (2012) (0)
Decay accelerating factor (CD55): the structure of an intact human complement regulator. (2004) (0)
A tale of tails: A novel approach to immunotherapy of prostate cancer (2017) (0)
Thrombalexin (a cytotopic thrombin inhibitor), successfully suppresses the innate immune response in a model of hepatocyte transplantation and may be a promising approach to improving cell engraftment (2016) (0)
Structural views of complement protein interactions (2004) (0)
Pregnancy-Associated Endometrial Protein in Women (1981) (0)
835 IL-15 inhibits expression of killer inhibitory NK receptors and upregulates expression of NKG2D on NK and NKT cells in prostate cancer-PBMC cocultures (2013) (0)
A Tale of Tails: A Novel Approach to Cytokine Immunotherapy (2014) (0)
Structure of a disulfide locked mutant of Intermedilysin with human CD59 (2013) (0)
Crystallisation and preliminary characterisation of crystals of complement component proteins (2004) (0)
C1 esterase inhibitor protects against peripheral ischemia/reperfusion injury and distant lung damage (2013) (0)
DraE adhesin from Escherichia Coli (2004) (0)
Abstract 4233: The protein ps20 increases resistance to docetaxel in PC3 and LNCAP prostate cancer cell lines (2012) (0)
Analysis of activated components of the complement system using optical biosensor techniques (1996) (0)
Kinetic analysis of the interaction between the complement regulators CD46 and CD55 and components of the alternative pathway of complement (2004) (0)
Non-Exchange of Streptokinase from Anisoylated Plasminogen Streptokinase Activator Complex and Other Acylated Streptokinase-Plasminogen Complexes (2012) (0)
Towards a CD59-based therapeutic: GPI anchor substitution with a membrane-targeting address (2001) (0)
Inhibition of thrombin on endothelium enhances recruitment of regulatory T cells during IRI and when combined with adoptive Treg transfer, significantly protects against acute tissue injury and prolongs allograft survival (2023) (0)
The novel Jagged1/CD46 interaction: A prime target for immune modulation by viruses? (2012) (0)
Derives solubles de cr1 (recepteur du complement de type 1) (1993) (0)
An intratumoural cytotopic immunotherapy approach to target prostate cancer in a syngeneic murine model (2019) (0)
Immunological preconditioning, including local complement inhibition, in ABO-incompatible auxiliary partial orthotopic liver transplantation as a bridge to definitive grafting in hyperacute liver failure: First report of a successful strategy (2007) (0)
An indium-111-labelled membrane-targeted peptide for cell tracking with radionuclide imaging (2022) (0)
Abstract 2582: Cytotopic IL-15 as a novel therapeutic for prostate cancer (2014) (0)
Abstract 268: Cytotopically modified antibodies to checkpoint proteins can actively reconstitute immune checkpoint blockade and inhibit tumor growth in a prostate cancer mouse model (2015) (0)
Prostate cancer cells enhance IL-15-mediated expansion of NK cells (2019) (0)
Shellfish Treasure Trove—New Writing by Marc Le Gros (1997) (0)
Improving decay-accelerating factor (DAF, CD55) by substituting a GPI-anchor with a membrane-targeting address (2001) (0)
Structural, kinetic and biochemical characterization of the oxidation states of human protein tyrosine phosphatase 1B: implications for redox regulation of phosphatase activity (2002) (0)
Automated Analysis of Protein Folding (1995) (0)
838 The protein ps20 increases tumorigenic potential in prostate cancer epithelial cells (2012) (0)
MP24-17 INTERLEUKIN-15 DOWNREGULATES INHIBITORY NATURAL KILLER(NK) CELL LIGANDS EXPRESSED ON PROSTATE CANCER CELLS RESULTING IN INCREASED NK CELL ACTIVITY IN PROSTATE CANCER-IMMUNE EFFECTOR CELL COCULTURES. (2014) (0)
Abstract 1175: Interleukin-15 activates NK and CD8 T cells within the Prostate cancer microenvironment by expanding activatory NK cell receptors and attenuating inhibitory HLA ligands on tumor cells (2014) (0)
Complex of E. Coli DraE adhesin with Chloramphenicol (2004) (0)
Attenuation of experimental acute myocardial infarction in pigs by Mirococept, a novel complement inhibitor derived from human complement receptor type 1 (2007) (0)
AfaE-3 adhesin from Escherichia Coli (2004) (0)
Immunologic Aspects of Prostate Cancer (2013) (0)
Abstract 4070: Combination of Interleukin-15 with a STING (Stimulator of Interferon Gene) agonist: A potential immunotherapy for prostate cancer (2019) (0)
Engineering Control of Complement Inhibition at the Cell Surface (2004) (0)
Theisozyme-specificeffectsofcyclooxygenase-deficiency onboneinmice (2006) (0)
Ending Poverty in Mongolia: From Socialism to Green Inclusive Growth? (2012) (0)
THERAPEUTIC STRATEGY FOR COUNTERACTING COMPLEMENT IN T CELL ACTIVATION: 1526 (2008) (0)
Interleukin-15 increases the lifespan and telomerase expression of CD8+ T, NK and NKT cells (2014) (0)
SeMet AfaE-3 adhesin from Escherichia Coli (2004) (0)
Rapid Communication A Recombinant , Chimeric Enzyme With a Novel Mechanism of Action Leading to Greater Potency and Selectivit Than Tissue-Type Plasminogen Activator (2005) (0)
MP61-05 IL-15 INCREASES NK FUNCTIONS IN THE PCA-LYMPHOCYTE MICROENVIRONMENT BY A PROFOUND INCREASE IN SHEDDING OF MICA FROM PCA CELLS – A NOVEL PARADIGM. (2015) (0)
10 Interleukin-15 boosts expansion of CD8 T, NK and NKT cells by upregulation of telomerase activity (2014) (0)

This paper list is powered by the following services:

Other Resources About Richard Smith

en.wikipedia.org

What Schools Are Affiliated With Richard Smith ?

Richard Smith is affiliated with the following schools:

Richard Smith 's Academic­Influence.com Rankings